These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7276579)

  • 1. Characterization of the recognition of target cells sensitive or resistant to cytolysis by activated rat peritoneal macrophages.
    Hamilton TA; Fishman M
    J Immunol; 1981 Oct; 127(4):1702-6. PubMed ID: 7276579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR; Wasserman AJ; Laskin DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
    North SM; Nicolson GL
    Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that a target-derived soluble factor is necessary for the selective lysis of SV40-transformed fibroblasts by activated mouse macrophages.
    Laster SM; Gooding LR
    J Immunol; 1990 Feb; 144(4):1438-43. PubMed ID: 2154519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO; Johnson WJ; Marino PA
    Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytolytic activity of macrophages from 5 strains of rats].
    Lagadec P; Jeannin JF; Milan C; Reisser D
    Pathol Biol (Paris); 1985 Feb; 33(2):107-10. PubMed ID: 3889779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulatory role of macrophage factors on rat lymphocyte reactivity.
    Brajczewska-Fischer W; Ryzewska A; Gorecka M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):407-10. PubMed ID: 749789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and lysis of altered-self cells by macrophages. I. Modification of target cells by 2,4,6-trinitrobenzene sulphonic acid.
    Kunin S; Gallily R
    Immunology; 1983 Feb; 48(2):265-72. PubMed ID: 6600441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial binding of macrophages to syngeneic cells elicits cytostasis but not cytolysis.
    Cabilly S; Gallily R
    Immunology; 1981 Jan; 42(1):149-55. PubMed ID: 7461722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R; Eidlen DM
    J Natl Cancer Inst; 1983 Nov; 71(5):983-9. PubMed ID: 6580500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemiluminescence and immune cell activation. II. Enhancement of concanavalin A-induced chemiluminescence following in vitro preincubation of rat thymocytes; dependency on macrophage-lymphocyte interaction.
    Wrogemann K; Weidemann MJ; Ketelsen UP; Wekerle H; Fischer H
    Eur J Immunol; 1980 Jan; 10(1):36-40. PubMed ID: 6965913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the recognition of target cells sensitive to or resistant to cytolysis by activated macrophages. II. Competitive inhibition of macrophage-dependent tumor cell killing by mitogen-induced, nonmalignant lymphoblasts.
    Hamilton TA; Fishman M
    Cell Immunol; 1982 Mar; 68(1):155-64. PubMed ID: 7083337
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation by macrophages of lymphocyte responses to phytohaemagglutinin, concanavalin A and semiallogeneic cells.
    Hem E
    Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):17-21. PubMed ID: 433602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and molecular characterization of macrophage-associated antigens of the rat.
    Veit BC; Hamilton TA; Kotb M
    J Immunol; 1982 Apr; 128(4):1700-4. PubMed ID: 6174612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.
    Adams DO
    J Immunol; 1980 Jan; 124(1):286-92. PubMed ID: 6985641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of defective and normal immunologic functions in lymphocytes and macrophages from osteopetrotic (op) rats.
    Hochman N; Wahl LM; Sandberg AL
    J Immunol; 1982 Jul; 129(1):278-81. PubMed ID: 7086133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
    Lavrovskiĭ VA; Iurchenko IuA; Guvakova MA
    Tsitologiia; 1987 May; 29(5):589-95. PubMed ID: 3617224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.